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Epigenetic modifications to the genome, including DNA methylation and histone modifi-
cations, occur in response to external stimuli. Reproductive function is highly sensitive to
environmental conditions including season, diet, hormonal changes, and exposure to chem-
ical contaminants. GnRH neurons, which play a key role in reproduction, are particularly
sensitive to various environmental stimuli. We recently reported that the rhesus monkey
GnRH gene exhibits distinct epigenetic changes during embryonic development. More
recently, we further found that a similar epigenetic phenomenon occurs across puberty. In
this article we highlight recent findings, including those of afferent inputs, to describe the
epigenetic control of GnRH circuit development as a link between the environment and
reproductive function.
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INTRODUCTION
Epigenetic mechanisms are responsible for the tremendous diver-
sity among cell phenotype and function. These mechanisms estab-
lish intricate patterns of modifications to DNA and histones, which
subsequently control gene expression profiles. Because epigenetic
modifications are sensitive to external stimuli, they provide a
means for cellular adaptation to environmental pressures. Given
the sensitivity of neuroendocrine systems to environmental con-
ditions, significant interest has grown over the epigenetic control
of neuroendocrine function.
The past decade has seen an explosion of neuroendocrine epi-
genetic research, primarily yielding patterns of DNA methylation
and histone modifications. To date, how these patterns are estab-
lished and whether those patterns are critical to neuroendocrine
function remains mostly a mystery. However, three reports (Kurian
et al., 2010; Iyer et al., 2011; Lomniczi et al., 2013) have recently
described epigenetic differences that seem critical to development
of the GnRH neuronal circuit, and more importantly appear to
pinpoint mechanisms responsible for those epigenetic phenom-
ena. This review synthesizes the findings of those reports to illus-
trate the promising future of epigenetic research in reproductive
neuroendocrine function.
DNA METHYLATION IN GnRH NEURONS
The GnRH neuron is a critical relay in the axis controlling
reproductive function. Specifically, its ability to release sufficient,
episodic pulses of GnRH peptide into the pituitary portal circula-
tion is essential for gametogenesis in both sexes and ovulation in
females. While upstream mechanisms fine-tune GnRH neuronal
activity, GnRH neurons also have an intrinsic capacity to release
GnRH peptide in a pulsatile manner.
GnRH neurons reside in the preoptic area and base of the hypo-
thalamus, among a complex milieu of other neurons and glia; this
presents a challenge for studying the cellular and molecular mech-
anisms of neuronal differentiation and function. Fortunately, the
unique ontogeny of GnRH neurons provides an opportunity to
isolate a GnRH neuronal population for in vitro studies. In the
rhesus monkey, these neurons differentiate from progenitor cells
in the nasal placode between embryonic (E) days 32–34 (Ron-
nekleiv and Resko, 1990; Quanbeck et al., 1997). GnRH neurons
subsequently begin migrating into the brain at about E36 and settle
down in the hypothalamus by E55 (Terasawa et al., 2001). Isolat-
ing the nasal placode after E34 but prior to migration provides
a neuronal population that consists of entirely GnRH neurons.
We found that placode tissue isolated on E36 developed typical
patterns of mature activity (e.g., GnRH peptide release; Terasawa
et al., 1993, 1999; Kurian et al., 2010) after about 2 weeks in vitro.
Wray and colleagues, who developed a similar murine in vitro cul-
ture model (Fueshko and Wray, 1994), have also reported a period
of gradual maturation after isolation from the nasal placode (Con-
stantin et al., 2009). In addition, they report that development of
GnRH peptide release patterns is paralleled by increasing GnRH
gene expression and peptide biosynthesis (Maurer and Wray,
1997; Moore and Wray, 2000). A question arises. What mecha-
nism triggers increasing gene expression during GnRH neuronal
development?
The genetic control of GnRH gene expression is well char-
acterized and depends on several cis sequences in the 5′ region
of the gene. The rat gene contains a neuron specific enhancer
region between−1863 and−1571 (Kepa et al., 1992, 1996b; Clark
and Mellon, 1995; Whyte et al., 1995). This spans a major region
of homology between the rat (−1786 to −1559) and human
(−2766 to−2539) genes. Interestingly, this portion of the human
gene does not appear to enhance gene expression; in fact, based
on serial truncations of the 5′ human GnRH gene in luciferase
assay constructs, it appears that this region impedes enhanced
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gene expression (Kepa et al., 1996a). Importantly, this area has
sequence similarity to a 5′ portion of the rhesus monkey GnRH
gene. We noticed that this distal 5′ region of the rhesus monkey
gene (Figure 1) contains a 243-bp segment (-2126 to -1863) that
has 60% GC content and a CpG (cytosine-guanine) dinucleotide
observed to expected ratio of 0.65 (14 CpG sites). These charac-
teristics define the region as a CpG island (CGI; Gardiner-Garden
and Frommer, 1987). CGIs, when associated with gene promoters,
are related to the epigenetic regulation (DNA methylation) of gene
expression (Deaton and Bird, 2011).
DNA methylation is the covalent addition of a methyl
(-CH3) group to nucleotides. Mammalian DNA-methyltransferase
(DNMT) enzymes catalyze this reaction, primarily at the 5′ car-
bon of cytosines in CpG dinucleotides. There are three primary
DNMT enzymes (1, 3a, and 3b), each critical to development as
demonstrated by embryonic or early postnatal lethality in mono-
genic null mouse models (Li et al., 1992; Okano et al., 1999).
DNMT1 is responsible for faithful maintenance of DNA methy-
lation after replication through cell division (Bestor and Ingram,
1983; Bestor et al., 1988; Hermann et al., 2004). DNMTs 3a and
3b are de novo methyltransferases responsible for newly acquired
methylation such as during the initial establishment of methyla-
tion patterns during early embryonic development (Okano et al.,
1998, 1999). Once established, DNA methylation can have sev-
eral impacts on gene transcription. Methylated DNA can directly
alter transcription factor recognition of cis sequences or attract
methyl-binding proteins thereby blocking genomic locations from
transcription factor assembly. In addition, methyl-binding pro-
teins (e.g., MeCP2, Mbd2, Kaiso) interact with histone modifying
factors to alter chromatin structure.
Until our recent studies (Kurian et al., 2010), there were no
reports of the epigenetic aspects of GnRH neuron maturation or
function. The CGI in the 5′ region of the rhesus monkey GnRH
gene was suggestive to us that DNA methylation has some role
in neuronal function. We hypothesized that increasing peptide
release during in vitro maturation of GnRH neurons would be
related to increased gene expression and changing DNA methyla-
tion patterns across the rhesus monkey GnRH gene, particularly
within the 5′CGI. As suspected, we found that GnRH mRNA levels
were low at day 0 but rose dramatically by day 20 of in vitro cul-
tures. This increase was paralleled by a dramatic decrease in CpG
FIGURE 1 | A Schematic representation of the rhesus monkey GnRH
gene depicting the location of the 5’ CpG island (CGI) and nucleotide
sequence of this region.This region is the only classifiable CGI within 2500
bases upstream of the GnRH gene transcription start site. CpG sites are
indicated with numbers corresponding to the CpG sites in Figures 2 and 3.
methylation status in the 5′ CGI (Figure 2). We also found that
a comparable phenomenon occurs across puberty. Similar to the
previous observation by Plant and colleagues showing that GnRH
mRNA levels increase between juvenile and pubertal stages in the
medial basal hypothalamus (MBH) of orchidectomized male rhe-
sus monkeys (El Majdoubi et al., 2000), we also observed that
GnRH mRNA levels increase in the male MBH across puberty
(Figure 3). Furthermore, methylation status of the 5′ CGI of the
GnRH gene was lower in adult compared to prepubertal male rhe-
sus monkeys (Figure 3; Kurian et al., 2011). This suggests to us that
developmental rises in GnRH gene expression are at least partly
the result of DNA demethylation across a CGI in the GnRH gene.
When evaluating these findings, it is important to consider
the distinct pattern of GnRH neuronal activity across develop-
ment. In primates, GnRH release is elevated, as indicated by
FIGURE 2 | Changes in GnRH mRNA levels and CGI methylation status
during GnRH neuronal development.Top panel – total RNA was
extracted from in vitro nasal placode cultures at 0, 14, and 20 div (n=4 in all
age groups). GnRH mRNA levels, measured by quantitative pcr, started to
increase after 14 div, reaching the highest level at 20 div. (*P <0.05 vs.
0 div; #P =0.05 vs. 14 div). GnRH mRNA levels are relative to 18 s in each
sample and analyzed using the ∆CT method. Bottom panel – GnRH
neurons dissected from the nasal placode region of two rhesus monkey
embryos at E36 and E37 were plated and then harvested on 0, 14, or 20 div.
DNA extracted from pooled samples (four cultures) at each time point was
bisulfite sequenced. Percent changes in methylation at each CpG site on
0 div (black bars), 14 div (gray bars), and 20 div (white bars) are shown. CpG
methylation status was significantly higher at 0 div compared with 20 div at
sites 4, 5, 6, 8, 9, 11, 12, and 14 (*P ≤0.01). CpG methylation status was
significantly higher at 0 div compared with 14 div at site 5 (#P <0.05) and at
0 div compared with 14 div but not 20 div at site 10 (##P < 0.05).
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FIGURE 3 | Changes in GnRH mRNA levels and CGI methylation status
across puberty in male rhesus monkey medial basal hypothalamic
(MBH) tissue. Top panel – total RNA and DNA was extracted from MBH
tissue of juvenile (n= 3, mean age 22.7±2.8 months) and adult (n=5,
mean age of 110±23.4 months) rhesus monkeys. GnRH mRNA levels,
measured by quantitative PCR, were higher in adult compared to juvenile
MBH (*P < 0.05). GnRH mRNA levels are relative to 18 s in each sample
and analyzed using the ∆CT method. Bottom panel – DNA extracted from
the same samples was bisulfite sequenced. Percent changes in methylation
at each CpG site for juvenile (black bars) and adult (white bars) MBH tissue
are shown. CpG methylation status was significantly higher in juvenile
compared to adult MBH samples sites 5, 6, 8, 9, 12, and 14 (*P ≤0.05).
peripheral luteinizing hormone levels, during a brief perinatal
period, but then decreases during juvenile development before
gradually increasing again through puberty. Our findings suggest
that each period of elevated GnRH release is related to demethy-
lation of the GnRH gene CGI. Specifically, in vitro maturation
is representative of embryonic development leading to elevated
activity during the perinatal period while measurements in MBH
tissue are indicative of developmental changes across pubertal
maturation. The decrease in methylation status across puberty
is indicative of two potential scenarios. One possibility is that the
process initiated in embryonic development might stall during
the juvenile period and subsequently resume at puberty onset.
Alternatively, the CGI may become re-methylated during juve-
nile development, and again demethylated at puberty onset. The
latter scenario would suggest that lower CpG methylation status
must be maintained to enable elevated GnRH gene expression.
Consequently, a mechanism responsible for DNA demethylation
and perhaps another mechanism responsible for maintaining
hypomethylated DNA might both be necessary for the transition
to puberty and maintenance of reproductive function. A com-
parison of CpG methylation status between perinatal and early
pubertal MBH tissue will be necessary to differentiate between
these two scenarios. Nonetheless, our current findings suggest that
DNA demethylation is an important aspect of GnRH neuronal
development and function.
ACTIVE DNA DEMETHYLATION IN GnRH NEURONS
Given the postmitotic/non-dividing state of GnRH neurons in
our in vitro cultures and across the pubertal transition measured
in MBH samples, the process of DNA demethylation we discov-
ered must be active. The mechanisms responsible for active DNA
demethylation are not well characterized, and until recently skepti-
cism has remained over the existence of this process in mammalian
systems.
DNA demethylation is achieved via two general mechanisms,
passive or active. Passive demethylation occurs through cell divi-
sions and interruption of maintenance methyltransferase activ-
ity. Current pharmaceutical approaches for DNA demethylation
target this mechanism. For example, 5-azacytidine (5-aza) is
metabolized and subsequently incorporated into DNA, where
it then acts as a substrate that covalently traps DNMTs after
methyl transfer to the 5-aza nitrogen (Schermelleh et al., 2005;
Svedruzic, 2008). Active demethylation is not well character-
ized. Several mechanisms are proposed, and intense efforts to
validate or better characterize these mechanisms continue. For
thorough background, we suggest a recent review (Wu and
Zhang, 2010) that outlines several promising pathways discov-
ered during the past decade. Presently, a well accepted mech-
anism is the sequential enzymatic process beginning with oxi-
dation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine
(5hmC), which is carried out by any one of three ten-eleven-
translocation enzymes (Tet 1–3). 5hmC is a stable epigenetic
modification, though under certain circumstances it is recog-
nized and excised by thymine DNA glycosylases. Base exci-
sion repair subsequently completes the transition. Importantly,
brain tissue, and particularly the hypothalamus, has the high-
est reported 5-hydroxymethylcytosine (5hmC) tissue abundance
(Branco et al., 2012). In addition, we recently reported that
increasing expression of Tet1 and Tet2 across neuronal matura-
tion could influence GnRH gene expression (Kurian and Terasawa,
2012).
Emerging physiological evidence also supports a role for Tet
enzymes in neuroendocrine development, and particularly the
control of reproductive function. For example, Tet1 knock out
mice exhibit deficits in fecundity. This effect is primarily a female
specific abnormality, as typical litter sizes result from crossing
wild-type females with Tet1 knockout males, whereas wild-type
males mated to Tet1 knockout females produces significantly fewer
offspring per litter (Dawlaty et al., 2011). A subsequent report
suggests this defect in fecundity might be the consequence of
abnormal progression of female germ cell development through
the second meiotic division prior to ovulation (Yamaguchi et al.,
2012). Interestingly, stimulation of the second meiotic division
and ovulation requires a GnRH driven LH surge (Mehlmann,
2005). Consequently, given the apparent active DNA demethy-
lation associated with GnRH neuronal development, the effect
of Tet depletion on abnormal reproductive function might be
the consequence of altered Tet mediated epigenetic differentia-
tion in the neuroendocrine hypothalamus. While hypothalamic
expression patterns of Tet enzymes are not yet reported, corti-
cal neuron expression is restricted to Tet2 and Tet3 (Hahn et al.,
2013). That this deficit in fecundity was even more pronounced in
double knockout (Tet1 and Tet2 knockout) mice (Dawlaty et al.,
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2013) gives further credence to the suggestion that Tet enzymes
are active in the hypothalamus to promote neuronal maturation
toward stage specific reproductive function.
As the mechanisms responsible for active demethylation in
GnRH neurons are discovered, the ultimate goal will be to char-
acterize how environmental factors influence those epigenetic
changes. It should be noted that GnRH neurons experience
dramatic shifts in environment during their development and
migration. In addition to traveling through or near several tis-
sue types, GnRH neurons are subjected to changing growth fac-
tor, chemokine and neurotransmitter levels, some of which form
gradients between the nasal region and forebrain (reviewed by
Wray, 2010). How these shifts in environment alter the epige-
netic landscape in GnRH neurons is yet to be defined, though
this background may prove instrumental to the characterization
of epigenetic mechanisms pertinent to GnRH neuron maturation.
HISTONE MODIFICATIONS IN GnRH NEURONAL FUNCTION
Histones are an integral component of nucleosomes, the primary
units for genome organization or compaction. Consequently, these
proteins, through interaction with DNA, have a critical role in
determining gene expression patterns. There are four primary
classes of histones, 1 through 4. Histones 2 through 4 are compo-
nents of the core octamer, which DNA circumnavigates in about
146 base pairs to form a single nucleosome. Histone 1 is a scaf-
fold protein, which tightly packages nucleosomes when present.
Several variants of this histone are distinguishable by sensitivity to
hormones (Banks et al., 2001). Histone 2 also has several variants
including A, AX, and B. Histone 2AX is particularly intriguing in
the context of neuronal maturation (Lee et al., 2010) and func-
tion based on its association with activity dependent DNA double
strand breaks in neurons (Suberbielle et al., 2013). Histones 3 and
4 complete the nucleosome octamer with histone 3 the most heav-
ily investigated in the realm of neuroendocrine function. Histone
3 has two variants, H3.3A and H3.3B. These variants are integral to
DNA replication independent histone switching, which would be
presumed an important mechanism in regulation of post mitotic
cell activity. To date, to our knowledge, nothing is reported regard-
ing the relationship between histone switching and hypothalamic
neuronal maturation or function.
Histone proteins package DNA largely due to their predom-
inant positive charge attracting negatively charged DNA. Post-
translational modifications (PTMs) alter the strength of that
attraction, and recruit or repel transcriptional machinery and his-
tone modifying enzymes. Consequently, these PTMs alter gene
accessibility and rates of transcription. Several known modifica-
tions include acetylation, phosphorylation, methylation, ubiquiti-
nation, sumoylation, and glcnacylation. To date, measurements of
histone PTMs in neuroendocrine systems have focused on acetyla-
tion and methylation. Acetylation leaves a more negative charge on
histones and consequently promotes transcription. Methylation is
neutral, and depending on the location and degree (mono, di, or
tri-methylation), can either promote or inhibit transcription.
Mellon and colleagues were the first to report a pattern of per-
missive histone modifications enabling elevated or mature GnRH
gene transcription (Iyer et al., 2011). Their studies capitalized on
the distinct stages of development between two GnRH neuronal
cell lines. GN11 cells, originally isolated from a tumor in the mouse
nasal placode (Radovick et al., 1991), express GnRH at very low
levels, whereas GT1 cells, which were isolated from an analogous
tumor in the mouse hypothalamus (Mellon et al., 1990), are char-
acterized by mature activity patterns including elevated GnRH
gene expression1. In essence, comparisons between these two cell
lines are similar to our evaluations of embryonic nasal placode
derived neurons from days 0 and 20 in vitro described above. They
found that the GnRH gene promoter and enhancer regions in
immature GN cells were more heavily associated with a repressive
histone modification: histone 3 (H3) lysine 9 (K9) di-methylation
(me2). On the other hand, the same genomic regions in GT1
cells were associated with the permissive H3K9 acetylation and
H3K4me3 PTMs. For comparison, they also evaluated these his-
tone PTM patterns in a non-neuronal (NIH3T3) cell line. The
repressive PTMs were high in NIH3T3 cells, intermediate in GN
cells and low in GT1 cells. The presence of permissive PTMs was
low and similar between NIH3T3 and GN cells but significantly
higher in mature GT1 cells.
TRANSACTIVATION OF BIVALENT DOMAINS IN
REPRODUCTIVE NEUROENDOCRINE FUNCTION
The intermediate repressive chromatin state in GN cells is indica-
tive of a bivalent promoter, where both repressive and permissive
histone PTMs maintain genes in a repressed albeit primed posi-
tion. These chromatin domains were first described in embryonic
stem (ES) cells and associated with developmentally regulated
transcription factors (Azuara et al., 2006; Bernstein et al., 2006; Pan
et al., 2007). Several recent reports, taken together, indicate that
establishment of bivalent domains through polycomb repressive
complex 2 (PRC2) and mixed lineage leukemia (MLL) is crit-
ical for neural lineage differentiation from ES cells (Yu et al.,
1995; Yagi et al., 1998; Glaser et al., 2006; Pasini et al., 2007;
Shen et al., 2008). The PRC2 component, Ezh2, is responsible for
H3K27 methylation, which is subsequently bound by the PRC1
complex to maintain tri-methylation at H3K27. MLL methylates
H3K4. Together, these complexes are proposed to establish a biva-
lent promoter, with the heavily repressive H3K27me3 mark in
close proximity to H3K4me. Interestingly, this particular bivalent
domain appears related to the juvenile repression and subsequent
activation of kisspeptin gene expression during the pubertal tran-
sition in female rats (Lomniczi et al., 2013). As a major stimulant
of GnRH release, this epigenetic regulation of kisspeptin expres-
sion may be instrumental in development of the mature GnRH
neuronal circuit.
1The developmental differences in the original GnRH cell lines (GN and GT1)
might be the consequence of typical epigenetic differentiation in the 5′ portion of
the GnRH gene. Each cell line was derived with a different portion of the GnRH
gene promoter driving SV40 expression/tumor initiation. GN cells were generated
using a short portion of the human GnRH promoter, which resulted in early tumor
production in the placode region, presumably shortly after differentiation from pre-
cursor cells. On the other hand, GT1 cells were derived from hypothalamic tumors
in animals that expressed SV40 driven by a longer 5′ portion of the rat promoter.
This longer promoter contains higher CpG content than the short human promoter
used for GN cell generation. Consequently, similar to our proposal that the distal 5′
region of the GnRH gene controls age specific expression of GnRH, developmental
epigenetic regulation of the GnRH promoter driven SV40 transgene may underlie
the difference in stage of tumor initiation between GN and GT1 cell lines.
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Similar to the findings of Mellon and colleagues comparing
GnRH gene promoter structure of immature and mature cell
lines, Lomniczi et al. (2013) recently reported that the female rat
pubertal transition is accompanied by increased prevalence of acti-
vating histone PTMs at the kisspeptin promoter. Specifically, prior
to puberty onset, the kisspeptin promoter was associated with a
bivalent domain (i.e., H3K27me3 and H3K4me3) and occupied
by a component of a polycomb repressive complex, EED. The
transition to puberty was accompanied by decreased EED occu-
pancy of the kisspeptin promoter, a gradual loss of the repressive
H3K27me3 PTM, and increased levels of the permissive H3K9,14
acetylation and H3K4me3 PTMs. The authors suggest this process
is the consequence of increased DNA methylation of the EED
promoter, leading to lower EED expression and consequential
decreased occupancy of the kisspeptin promoter by the repres-
sive PRC2 (EED, SUZ12, Ezh2) complex. These conclusions were
largely based on observations of dramatically delayed puberty in
female mice when DNA methylation was inhibited by peripheral
administration of the pharmacological DNA-methyltransferase
inhibitor 5-azacytidine (5-aza). While the conclusions are consis-
tent with the observations, this 5-aza activity may not be specific
to inhibition of post mitotic neuronal DNA methylation. Because
the well-characterized mechanism of 5-aza requires nucleoside
incorporation into DNA (Schermelleh et al., 2005; Stresemann
and Lyko, 2008; Svedruzic, 2008) the mechanism of DNMT inhi-
bition in post mitotic cells by this compound remains unclear. In
addition, a significant reduction in growth rate and elevated lev-
els of plasma corticosterone after the initiation of drug treatment
(Lomniczi et al., 2013) is indicative of toxicities that likely con-
tribute to delays in maturation. Because of these concerns, more
direct approaches (e.g., cell specific genetic or enzyme expres-
sion manipulations) will be necessary to clarify the relationship
between DNA methylation, chromatin modifications, and puberty
onset. Nonetheless, these studies are instrumental to the notion
that structural modification of bivalent promoters in the neuroen-
docrine hypothalamus is an integral step toward puberty onset and
reproductive function.
Lomniczi and colleagues’ focused approach toward measur-
ing histone modification status across development at one gene
has tremendous value for clarifying the temporal progression of
bivalent promoter transactivation. Importantly, they report that
permissive histone PTMs (H3K4me3 and H3K9,14 acetylation)
accumulate near the kisspeptin promoter during the transition
from juvenile to early pubertal stages. This preceded loss of the
repressive H3K27me3 PTM, suggesting that recruitment of acti-
vating complexes is imperative for transactivation and increased
gene expression. Interestingly, a recent discovery points to Tet
enzymes as critical mediators of activation at bivalent promot-
ers during neuronal differentiation. Specifically, while Ezh2 (the
H3K27 methyltransferase component of PRC2) is critical for pro-
gression of neuronal precursor cells toward a neuronal fate, Tet2
or Tet3 appear to complete the process of differentiation. In
fact, these studies also found that accumulation of intragenic 5-
hydroxymethylcytosine is associated with loss of H3K27me3 near
regions with the most significant gene activation during neu-
ronal differentiation. In addition, Tet2 was recently reported to
promote H3K4me3 through association with the Set1/COMPASS
complex (Deplus et al., 2013). The increasing H3K9,14 acetyla-
tion likely indicate RNA Polymerase II associated acetyltransferase
(e.g., p300, CBP, PCAF, Gcn5) activity. Though it is possible that
this PTM also directs the establishment or maintenance of Tet
mediated H3K4 methylation as H3K9,14 acetylation attracts 14-
3-3 (Winter et al., 2008), a Tet2 interacting partner (Deplus et al.,
2013).
In addition to activation, shifting chromatin structures also
enable maintenance or deeper repression at some bivalent pro-
moters across development; for example, neuronal lineage devel-
opment depends on Jarid1b, which strips H3K4 methylation,
consequently repressing bivalent promoters (Schmitz et al., 2011).
The histone lysine demethylase, LSD1, has a similar role in
chromatin modification, demethylating both di- and mono-
methylated H3K4. Importantly, recent preliminary studies (Gill
et al., 2012a) found that heterozygous LSD1 knockout female
mice exhibit precocious vaginal opening and first ovulation
(3–4 days prior to wild-type littermates) with early elevations
of plasma gonadotropins and hypothalamic expression of the
puberty related gene, tac2 (neurokinin B; Gill et al., 2012b).
These findings are analogous to those of Lomniczi et al. (2013),
in that lower expression of an epigenetic repressive enzyme is
related to elevated hypothalamic expression of a puberty related
gene. However, LSD1 expression or activity changes across typi-
cal development are currently unknown. In addition, LSD1 also
stimulates hormone (ligand associated androgen receptor) medi-
ated gene activation through demethylation of H3K9 (Metzger
et al., 2005). Consequently, while preliminary evidence suggests
the intriguing possibility that LSD1 directly alters hypothalamic
development (including GnRH and kisspeptin neurons) dur-
ing the pubertal transition, models for cell or region specific
genetic manipulations will be necessary to verify this interpre-
tation. These models will be critical for determining the pri-
mary activity of LSD1 (i.e., H3K4 or H3K9 demethylation)
as it relates to GnRH circuit development and reproductive
maturation.
CONCLUSION
Our understanding of epigenetic regulation of GnRH neurons and
neuroendocrine function in general is in its infancy, though the
three reports detailed in this review indicate the importance of a
shifting epigenetic structure at genes responsible for the develop-
ment of reproductive function. Presently, DNA methylation and
histone modifications both appear to influence levels of GnRH
gene expression through neuronal maturation. On the other hand,
kisspeptin gene expression appears most heavily influenced by
histone modifications alone in the developing postnatal hypothal-
amus (Semaan et al., 2012; Tomikawa et al., 2012; Semaan and
Kauffman, 2013). Importantly, a similar histone signature (i.e.,
bivalent domain) seems integral to the development of GnRH
and kisspeptin neurons. Specifically, evidence is mounting that
activation of a bivalent promoter (Lomniczi et al., 2013) and
maintenance of a permissive chromatin state (Iyer et al., 2011)
play crucial roles in pubertal maturation and GnRH neuronal
function, respectively. Presently, the activating component is not
characterized, though evidence points to a Tet enzyme (Kurian
and Terasawa, 2012) complex. Decreasing expression or activity of
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repressive epigenetic enzymes (i.e., PRC2 components or LSD1)
may also have a significant role in promoter structure and gene
activation in the developing hypothalamus. How these activat-
ing and repressive complexes are directed to specific promoters
and whether shifts in genomic localization are critical to GnRH
circuit development and function remains to be determined.
Nonetheless, with these targets to investigate, an understanding of
GnRH neuron biology and the means by which an environment
modifies neuronal function (i.e., epigenetic modifications), lies at
our fingertips.
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